Trials / Completed
CompletedNCT02391090
FeNO After Hypoxia in Asthma Patients
Effects of Intermittent Hypoxia on the Asthmatic Inflammation of Asthma Patients - a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Stable Asthma patients (GINA 1-2) stay 6 days in a row for 4 hours per day in a hypoxic chamber simulating 2800m above sea level. Study participants will be blinded to the treatment given and divided into a hypoxic and a sham group (about 360m above sea level). Effects of this intermittent hypoxia on the asthmatic inflammation of these patients will be measured. The primary endpoint is the change in forced exhaled nitric oxide (FeNO) before and after the study. Secondary endpoints include blood parameters, lung function testing and questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hypoxia in hypoxic chamber | Intervention lasts 4 hours per day for 6 days in a row. |
| DEVICE | sham hypoxia in hypoxic chamber | Intervention lasts 4 hours per day for 6 days in a row. |
| PROCEDURE | Pulse oximetry | Pulse oximetry will be performed hourly during sessions in the hypoxic chamber for safety reasons. |
| OTHER | Asthma and Quality of Life Questionnaires | Before every session in the hypoxic chamber as well as on the day after the last session will be completed. |
| PROCEDURE | Lung function testing | On the day of the first session in the hypoxic chamber as well as on the day after the last session lung function testing will be performed. |
| PROCEDURE | Blood taking | On the day of the first session in the hypoxic chamber as well as on the day after the last session blood samples will be taken. |
| PROCEDURE | FeNO measurement | Before every session in the hypoxic chamber as well as on the day after the last session FeNO (forced exhaled nitric oxide) measurement will be performed. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-03-18
- Last updated
- 2015-03-18
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02391090. Inclusion in this directory is not an endorsement.